Dora Menchaca

Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.

E. Shpall, L. Chap, J. Glaspy, 1997, Blood.

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo

G. Demetri, S. Galli, A. Dvorak, 1996, The Journal of experimental medicine.

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

C. Begley, J. Rasko, C. Begley, 1996, The Lancet.

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.

R. Figlin, J. Crawford, L. Harker, 1997, The New England journal of medicine.

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor.

C. Begley, C. Begley, M. Edmonds, 2002, Blood.